A LOW-ANTICOAGULANT HEPARIN: PURIFICATION PROCESS, TOXIC EFFECTS, AND ANTIMETASTATIC POTENTIAL IN VIVO

- 315233
IC - Undergraduate Students
Favorite this paper
How to cite this paper?
Abstract

INTRODUCTION AND OBJECTIVE: Numerous studies have shown that unfractionated heparin (UFH) presents a broad pharmacological potential not only in treating diseases related to blood clot formation, but also cancer, inflammation, and viral infections. However, the clinical use of porcine UFH for these alternative purposes requires doses that represent a high risk of hemorrhage. Our group described that the bovine UFH consists of two distinct heparin chains with different chemical compositions and anticoagulant activities, and separable by ion-exchange chromatography. One of these fractions is the low-anticoagulant heparin (LABH). The original purification process requires hours of work and many HPLC runs for a small amount of product, therefore, we recently optimized this process. This study aimed to compare two methodologies of LABH purification, examine its antitumoral and antimetastatic capacity and also its potential renal and hepatic toxicity in mice. MATERIAL AND METHODS: Initially LABH used to be fractionated by ion exchange chromatography, but we developed a new methodology to purify LABH by precipitation with CPC and compared their performance and anticoagulant activity. Next, healthy C57BL/6 mice were treated for 3 consecutive days with 20 mg/kg of LABH and the peripheral blood, liver and kidneys were collected for analysis of toxicity. For the antimetastatic assays, mice were previously treated subcutaneously with porcine UFH or LABH, and subsequently were challenged with LLC (lung carcinoma) or B16F10 (melanoma) cells intravenously. Some experimental groups received daily administration of the heparins until the end of the experiment. After 21 days, lungs were analyzed in order to check macro- and micrometastasis. RESULTS AND CONCLUSION: Comparing the methodologies of LABH purification, we could obtain a quite similar LABH by precipitation with the benefit of reducing the time of work and having approximately 10 times more product at the end. Concerning the in vivo data, no significant histological difference was verified in the renal and hepatic tissues of LABH-treated and control mice. Aspartate aminotransferase (AST) and total bilirubin (TBILC) levels were similar, but a small reduction in alkaline phosphatase (ALP) was seen in LABH-treated group. In another set of experiments, it was observed that LABH reduced macro- and micrometastasis as well as the lung tumor committed area both in LLC and B16F10 attempts. In summary, LABH seems to be safer than porcine UFH and displays an interesting antitumor and antimetastatic potential with lower toxicity in vivo.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal do Rio de Janeiro
  • 2 Universidade Federal do Rio de Janeiro | (Federal University of Rio de Janeiro)
  • 3 Universidade Federal do Rio de Janeiro (UFRJ)
Track
  • 5. Metabolism and Glycobiology
Keywords
metastasis
low-anticoagulant heparin
toxicity